EvoEndo Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$2.25M
- Investors
-
12
EvoEndo General Information
Description
Developer of a single-use endoscopy system designed to offer unsedated endoscopy procedures for pediatric and adult patients. The company's system uses a virtual reality-based distraction method for eliminating the need for anesthesia and customized medical-grade software to integrate the system, enabling patients to reduce the complexity, cost, and apprehension associated with pediatric endoscopy procedures.
Contact Information
Website
www.evoendo.comCorporate Office
- 888 East Belvidere Road
- Suite 212
- Grayslake, IL 60030
- United States
Corporate Office
- 888 East Belvidere Road
- Suite 212
- Grayslake, IL 60030
- United States
EvoEndo Timeline
EvoEndo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Debt - General | 01-Jul-2024 | $2.25M | Completed | Generating Revenue | ||
| 8. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 7. Later Stage VC (Series A) | 07-Sep-2023 | Completed | Generating Revenue | |||
| 6. Grant | 01-Jun-2022 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 19-Apr-2022 | Completed | Generating Revenue | |||
| 4. Grant | 14-Feb-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 2. Seed Round | 08-Jun-2021 | $10.1M | $10.1M | Completed | Generating Revenue | |
| 1. Grant | 21-May-2019 | $250K | Completed | Generating Revenue |
EvoEndo Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-7 | ||||||||
| Series A-6 | ||||||||
| Series A-5 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed-2 | 762,775 | $0.000100 | $3.36 | $3.36 | 1x | $3.36 | 1.83% | |
| Seed-1 | 3,206,303 | $0.000100 | $3.36 | $3.36 | 1x | $3.36 | 7.7% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
EvoEndo Comparisons
Industry
Financing
Details
EvoEndo Competitors (13)
One of EvoEndo’s 13 competitors is Advanced Sterilization Products, a Corporate Backed or Acquired company based in Irvine, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Advanced Sterilization Products | Corporate Backed or Acquired | Irvine, CA | ||||
| CivaTech Oncology | Venture Capital-Backed | Durham, NC | ||||
| PENTAX Medical | Corporation | Tokyo, Japan | ||||
| SPR Therapeutics | Formerly VC-backed | Cleveland, OH | ||||
| Arthrex | Private Equity-Backed | Naples, FL |
EvoEndo Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
EvoEndo Patents
EvoEndo Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12690754-B2 | Endoscopy device having a push-button brake and stabilization mechanism | Active | 25-Oct-2024 | ||
| US-20260114721-A1 | Endoscopy device having a push-button brake and stabilization mechanism | Active | 25-Oct-2024 | ||
| US-20260114722-A1 | Endoscopy device having a push-button brake and stabilization mechanism | Pending | 25-Oct-2024 | ||
| WO-2026090581-A2 | Endoscopy device having a push-button brake and stabilization mechanism | Pending | 25-Oct-2024 | ||
| WO-2026090581-A3 | Endoscopy device having a push-button brake and stabilization mechanism | Pending | 25-Oct-2024 | A61B1/0052 |
EvoEndo Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
EvoEndo Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| American Gastroenterological Association | Corporation | Minority | ||
| AdvaMed Accel | Corporation | |||
| Medmarc Casualty Insurance Company | Corporation | |||
| MedTech Innovator | Accelerator/Incubator | |||
| AllerFund Ventures | Venture Capital | Minority |
EvoEndo FAQs
-
When was EvoEndo founded?
EvoEndo was founded in 2017.
-
Where is EvoEndo headquartered?
EvoEndo is headquartered in Grayslake, IL.
-
What is the size of EvoEndo?
EvoEndo has 19 total employees.
-
What industry is EvoEndo in?
EvoEndo’s primary industry is Surgical Devices.
-
Is EvoEndo a private or public company?
EvoEndo is a Private company.
-
What is EvoEndo’s current revenue?
The current revenue for EvoEndo is .
-
How much funding has EvoEndo raised over time?
EvoEndo has raised $30.9M.
-
Who are EvoEndo’s investors?
American Gastroenterological Association, AdvaMed Accel, Medmarc Casualty Insurance Company, MedTech Innovator, and AllerFund Ventures are 5 of 12 investors who have invested in EvoEndo.
-
Who are EvoEndo’s competitors?
Advanced Sterilization Products, CivaTech Oncology, PENTAX Medical, SPR Therapeutics, and Arthrex are some of the 13 competitors of EvoEndo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
